BRIGHTVIEW HOLDINGS INC (BV)

US10948C1071 - Common Stock

12.66  +0.12 (+0.96%)

After market: 12.66 0 (0%)

Fundamental Rating

4

Overall BV gets a fundamental rating of 4 out of 10. We evaluated BV against 85 industry peers in the Commercial Services & Supplies industry. BV has an average financial health and profitability rating. BV has a correct valuation and a medium growth rate.



4

1. Profitability

1.1 Basic Checks

BV had positive earnings in the past year.
BV had a positive operating cash flow in the past year.
In multiple years BV reported negative net income over the last 5 years.
BV had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

BV has a Return On Assets of 0.97%. This is comparable to the rest of the industry: BV outperforms 48.19% of its industry peers.
BV has a Return On Equity (1.87%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 3.22%, BV is doing worse than 60.24% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BV is significantly below the industry average of 10.11%.
The 3 year average ROIC (2.62%) for BV is below the current ROIC(3.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.97%
ROE 1.87%
ROIC 3.22%
ROA(3y)0.54%
ROA(5y)0.36%
ROE(3y)1.39%
ROE(5y)0.87%
ROIC(3y)2.62%
ROIC(5y)2.57%

1.3 Margins

With a Profit Margin value of 1.16%, BV perfoms like the industry average, outperforming 46.99% of the companies in the same industry.
BV has a Operating Margin of 4.19%. This is comparable to the rest of the industry: BV outperforms 42.17% of its industry peers.
BV's Operating Margin has improved in the last couple of years.
BV has a Gross Margin of 23.85%. This is in the lower half of the industry: BV underperforms 61.45% of its industry peers.
BV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.19%
PM (TTM) 1.16%
GM 23.85%
OM growth 3Y34.87%
OM growth 5Y16.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.69%
GM growth 5Y-1.95%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BV is destroying value.
BV has more shares outstanding than it did 1 year ago.
BV has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BV has been reduced compared to a year ago.

2.2 Solvency

BV has an Altman-Z score of 1.46. This is a bad value and indicates that BV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.46, BV is doing worse than 65.06% of the companies in the same industry.
The Debt to FCF ratio of BV is 6.61, which is on the high side as it means it would take BV, 6.61 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BV (6.61) is better than 60.24% of its industry peers.
BV has a Debt/Equity ratio of 0.50. This is a neutral value indicating BV is somewhat dependend on debt financing.
BV's Debt to Equity ratio of 0.50 is in line compared to the rest of the industry. BV outperforms 59.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.61
Altman-Z 1.46
ROIC/WACC0.38
WACC8.49%

2.3 Liquidity

A Current Ratio of 1.67 indicates that BV should not have too much problems paying its short term obligations.
With a Current ratio value of 1.67, BV perfoms like the industry average, outperforming 59.04% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that BV should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.67, BV is doing good in the industry, outperforming 71.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67

4

3. Growth

3.1 Past

BV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.56%.
BV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.45% yearly.
Looking at the last year, BV shows a small growth in Revenue. The Revenue has grown by 1.16% in the last year.
BV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.65% yearly.
EPS 1Y (TTM)5.56%
EPS 3Y-15.45%
EPS 5YN/A
EPS growth Q2Q257.14%
Revenue 1Y (TTM)1.16%
Revenue growth 3Y6.28%
Revenue growth 5Y3.65%
Revenue growth Q2Q3.46%

3.2 Future

Based on estimates for the next years, BV will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.24% on average per year.
The Revenue is expected to grow by 2.05% on average over the next years.
EPS Next Y33.39%
EPS Next 2Y21.47%
EPS Next 3Y19.24%
EPS Next 5YN/A
Revenue Next Year0.86%
Revenue Next 2Y1.89%
Revenue Next 3Y2.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.66 indicates a correct valuation of BV.
Based on the Price/Earnings ratio, BV is valued a bit cheaper than 78.31% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.28. BV is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 15.60, BV is valued correctly.
Based on the Price/Forward Earnings ratio, BV is valued a bit cheaper than the industry average as 73.49% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.88, BV is valued a bit cheaper.
Industry RankSector Rank
PE 16.66
Fwd PE 15.6

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BV is valued cheaply inside the industry as 83.13% of the companies are valued more expensively.
83.13% of the companies in the same industry are more expensive than BV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.98
EV/EBITDA 7.29

4.3 Compensation for Growth

BV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BV's earnings are expected to grow with 19.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y21.47%
EPS Next 3Y19.24%

0

5. Dividend

5.1 Amount

No dividends for BV!.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (5/3/2024, 7:04:01 PM)

After market: 12.66 0 (0%)

12.66

+0.12 (+0.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.20B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.66
Fwd PE 15.6
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.97%
ROE 1.87%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.19%
PM (TTM) 1.16%
GM 23.85%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)5.56%
EPS 3Y-15.45%
EPS 5Y
EPS growth Q2Q
EPS Next Y33.39%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.16%
Revenue growth 3Y6.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y